IP Library Granted Patent US 12,502,511
Granted Patent B2
US 12,502,511 · App. 18/215,934 · Granted Dec 23, 2025

Methods and devices for paranasal sinus drug delivery

Inventors: Peter T. Keith (Lanesboro, MN); Reuben C. Setliff, III (Sioux Falls, SD)
Assignee: Stryker Corporation
A61M25/1002A61B17/24A61M25/0012A61M27/002A61F2/186A61F2250/0059A61F2250/0068A61M2025/1004A61M2025/1054A61M2210/0681
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,502,511
App. No.
18/215,934
Granted
Dec 23, 2025
Kind
B2
Abstract

Described herein are methods and devices for delivering a drug to the frontal sinus system. An inflatable implant is positioned within the frontal sinus system using an anchoring means secured within the frontal sinus cavity. A drug-containing fluid is released directly into the frontal sinus drainage system.

Claims (37)

1 . A drug delivery system, comprising:

a shaft extending between a proximal portion and a distal portion;

a fluid reservoir coupled to the distal portion of the shaft such that the fluid reservoir extends around an exterior of the shaft, wherein the fluid reservoir comprises a rigid, non-inflatable container that is configured to contain a fluid;

a dispensing structure in fluid communication with the fluid reservoir, wherein the dispensing structure comprises a plurality of ports that are configured to dispense the fluid; and

an anchoring structure configured to extend within a sinus cavity to position and retain the dispensing structure in a drainage pathway of the sinus cavity.

2 . The drug delivery system of claim 1 , wherein the anchoring structure extends distally of the fluid reservoir.

3 . The drug delivery system of claim 2 , wherein the anchoring structure comprises a plurality of retention wings that extend distally and radially outward from a distal tip coupled to a distal end of the shaft.

4 . The drug delivery system of claim 3 , wherein a portion of the plurality of retention wings are embedded in the distal tip.

5 . The drug delivery system of claim 2 , further comprising a core in a lumen of the shaft,

wherein the anchoring structure is coupled to the core,

wherein the core and the anchoring structure are configured to move relative to the fluid reservoir and the shaft to adjust a relative position between (i) the fluid reservoir and the dispensing structure and (ii) the anchoring structure.

6 . The drug delivery system of claim 5 , wherein the core is frictionally engaged with a distal tip that is coupled to a distal end of the shaft.

7 . The drug delivery system of claim 5 , wherein the core is frictionally engaged with a valve that is located in a lumen of the shaft between a proximal end of the shaft an da distal end of the shaft.

8 . The drug delivery system of claim 1 , wherein the anchoring structure is coupled to the shaft at a location that is proximal of the fluid reservoir.

9 . The drug delivery system of claim 1 , wherein an outer diameter of the anchor structure is configured to expand, relative to a central axis of the shaft, from a first diameter to a second diameter.

10 . The drug delivery system of claim 9 , further comprising a sheath that is movable along the shaft between a distal position and a proximal position,

wherein the sheath compresses the anchor structure to the first diameter when the sheath is in the distal position, and

wherein the anchoring structure expands to the second diameter when the sheath is in the proximal position.

11 . The drug delivery system of claim 1 , further comprising a one-way valve between a lumen of the shaft and an interior cavity of the fluid reservoir.

12 . The drug delivery system of claim 11 , wherein the shaft further comprises a flow port in a wall of the shaft at a location that is distal of the one-way valve and proximal of a distal end of the shaft.

13 . The drug delivery system of claim 1 , wherein the dispensing structure comprises a plurality of ports along the shaft.

14 . The drug delivery system of claim 1 , wherein the dispensing structure comprises a plurality of ports through a wall of the fluid reservoir.

15 . A drug delivery system, comprising:

a shaft extending between a proximal portion and a distal portion;

a fluid reservoir coupled to the distal portion of the shaft, wherein the fluid reservoir comprises a rigid container that is configured to contain a fluid;

a dispensing structure in fluid communication with the fluid reservoir, wherein the dispensing structure comprises a plurality of ports that are configured to dispense the fluid; and

an anchoring structure configured to extend within a sinus cavity to position and retain the dispensing structure in a drainage pathway of the sinus cavity,

wherein the shaft comprises an outer tube and an inner tube,

wherein the inner tube is disposed in a first lumen of the outer tube,

wherein the inner tube defines a second lumen,

wherein the fluid reservoir is in fluid communication with the inner tube via a flow port in the inner tube, wherein the fluid reservoir is further in fluid communication with the first lumen of the outer tube via a gap between the inner tube and the outer tube, and

wherein the inner tube, the fluid reservoir, the outer tube, and the dispensing structure define a fluid pathway such that the fluid flows (i) distally along the second lumen of the inner tube, (ii) from the second lumen of the inner tube to the fluid reservoir via the flow port, (iii) from the fluid reservoir to the first lumen of the outer tube via the gap between the inner tube and the outer tube, (iv) proximally along the first lumen of the outer tube to the dispensing structure, and (v) through the dispensing structure to the drainage pathway of the sinus cavity.

16 . The drug delivery system of claim 15 , wherein the fluid reservoir has a proximal end and a distal end, wherein the inner tube extends through the proximal end of the fluid reservoir to the distal end of the fluid reservoir.

17 . The drug delivery system of claim 16 , the proximal end of the fluid reservoir is coupled to outer tube.

18 . The drug delivery system of claim 16 , the distal end of the fluid reservoir is coupled to inner tube.

19 . The drug delivery system of claim 15 , further comprising a cap at a distal end of the inner tube, wherein the cap is configured to assist in directing the fluid from the second lumen of the inner tube to the flow port.

20 . The drug delivery system of claim 15 , wherein the outer tube is sealed to the inner tube a location that is proximal of the dispensing structure such that fluid is prevented from flowing along the first lumen proximally past the location at which the outer tube is sealed to the inner tube.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2025
From: ENTELLUS MEDICAL, INC.
To: STRYKER CORPORATION
Reel/Frame 069827/0553 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2023
From: KEITH, PETER T.; SETLIFF, III, REUBEN C., MD
To: ENTELLUS MEDICAL, INC.
Reel/Frame 064635/0709 →
Continuity (6)
Continuation 17081548 · Oct 27, 2020
Continuation 16019356 · Jun 26, 2018
Continuation 15140474 · Apr 28, 2016
Continuation 12766586 · Apr 23, 2010
Provisional Application 61172426 · Apr 24, 2009
Related Publication 20230381467A1 · Nov 30, 2023
References Cited (77)
US 3742960A · Dye et al. · 1973 [cited by applicant]
US 4737141A · Spits · 1988 [cited by examiner]
US 5611775A · Machold · 1997 [cited by applicant]
US 6543452B1 · Lavigne · 2003 [cited by examiner]
US 7410480B2 · Muni · 2008 [cited by applicant]
US 7419497B2 · Muni et al. · 2008 [cited by applicant]
US 7520876B2 · Ressemann et al. · 2009 [cited by applicant]
US 7678099B2 · Ressemann et al. · 2010 [cited by applicant]
US 7842062B2 · Keith et al. · 2010 [cited by applicant]
US 7879061B2 · Keith et al. · 2011 [cited by applicant]
US 7918871B2 · Truitt et al. · 2011 [cited by applicant]
US 8241266B2 · Keith et al. · 2012 [cited by applicant]
US 8277478B2 · Drontle et al. · 2012 [cited by applicant]
US 8282667B2 · Drontle et al. · 2012 [cited by applicant]
US 8348969B2 · Keith et al. · 2013 [cited by applicant]
US 8568439B2 · Keith et al. · 2013 [cited by applicant]
US 8585728B2 · Keith et al. · 2013 [cited by applicant]
US 8585729B2 · Keith et al. · 2013 [cited by applicant]
US 8623043B1 · Keith et al. · 2014 [cited by applicant]
US 8657846B2 · Keith et al. · 2014 [cited by applicant]
US 8801670B2 · Drontle et al. · 2014 [cited by applicant]
US 8834513B2 · Hanson et al. · 2014 [cited by applicant]
US 8882795B2 · Drontle et al. · 2014 [cited by applicant]
US 8888686B2 · Drontle et al. · 2014 [cited by applicant]
US 8915938B2 · Keith et al. · 2014 [cited by applicant]
US 8986340B2 · Drontle et al. · 2015 [cited by applicant]
US 9005284B2 · Ressemann · 2015 [cited by applicant]
US 9101739B2 · Lesch, Jr. et al. · 2015 [cited by applicant]
US 9192748B2 · Ressemann et al. · 2015 [cited by applicant]
US 9278199B2 · Keith et al. · 2016 [cited by applicant]
US 9282986B2 · Hanson et al. · 2016 [cited by applicant]
US 9283360B2 · Lesch et al. · 2016 [cited by applicant]
US 9320876B2 · Ressemann et al. · 2016 [cited by applicant]
US 9333327B2 · Setliff, III et al. · 2016 [cited by applicant]
US 9339637B2 · Drontle et al. · 2016 [cited by applicant]
US 9370650B2 · Hanson et al. · 2016 [cited by applicant]
US 9433343B2 · Drontle et al. · 2016 [cited by applicant]
US 9440049B2 · Drontle et al. · 2016 [cited by applicant]
US 9486614B2 · Drontle et al. · 2016 [cited by applicant]
US 9550049B2 · Hanson et al. · 2017 [cited by applicant]
US 9694167B2 · Keith et al. · 2017 [cited by applicant]
US 9700705B2 · Lesch, Jr. et al. · 2017 [cited by applicant]
US 9775975B2 · Ressemann et al. · 2017 [cited by applicant]
US 10022525B2 · Hanson et al. · 2018 [cited by applicant]
US 10029069B2 · Keith et al. · 2018 [cited by applicant]
US 10086181B2 · Lesch · 2018 [cited by applicant]
US 20010047163A1 · Samson · 2001 [cited by applicant]
US 20030100887A1 · Scott et al. · 2003 [cited by applicant]
US 20060205992A1 · Lubock · 2006 [cited by examiner]
US 20080015540A1 · Muni · 2008 [cited by examiner]
US 20080172033A1 · Keith et al. · 2008 [cited by applicant]
US 20090018500A1 · Carter · 2009 [cited by examiner]
US 20090171301A1 · Becker · 2009 [cited by applicant]
US 20090187258A1 · Ip · 2009 [cited by applicant]
US 20090198216A1 · Muni · 2009 [cited by applicant]
US 20120283625A1 · Keith et al. · 2012 [cited by applicant]
US 20130030458A1 · Drontle et al. · 2013 [cited by applicant]
US 20130072958A1 · Ressemann et al. · 2013 [cited by applicant]
US 20130123833A1 · Lesch et al. · 2013 [cited by applicant]
US 20140350520A1 · Drontle et al. · 2014 [cited by applicant]
US 20140354959A1 · Hanson et al. · 2014 [cited by applicant]
US 20140364700A1 · Hanson et al. · 2014 [cited by applicant]
US 20140378776A1 · Hanson et al. · 2014 [cited by applicant]
US 20150031950A1 · Drontle et al. · 2015 [cited by applicant]
US 20150045827A1 · Drontle et al. · 2015 [cited by applicant]
US 20150105818A1 · Keith et al. · 2015 [cited by applicant]
US 20160151614A1 · Ressemann et al. · 2016 [cited by applicant]
US 20160166814A1 · Lesch et al. · 2016 [cited by applicant]
US 20160367286A1 · Drontle et al. · 2016 [cited by applicant]
US 20170007282A1 · Drontle · 2017 [cited by applicant]
US 20170028112A1 · Drontle et al. · 2017 [cited by applicant]
US 20170050001A1 · Drontle et al. · 2017 [cited by applicant]
US 20170113027A1 · Drontle et al. · 2017 [cited by applicant]
US 20170119952A1 · Wen · 2017 [cited by examiner]
US 20170368319A1 · Esch et al. · 2017 [cited by applicant]
US 20180008806A1 · Ressemann et al. · 2018 [cited by applicant]
US 20180304058A1 · Hanson et al. · 2018 [cited by applicant]